Acesso livre
Acesso livre

Geriatria

Cuidados paliativos e de fim de vida: priorizando a compaixão dentro da UTI e além dela.

27 Set, 2021 | 11:16h

Palliative and End-of-Life Care: Prioritizing Compassion Within the ICU and Beyond – Critical Care Medicine

AAOS atualiza diretriz de prática clínica sobre osteoartrose do joelho.

27 Set, 2021 | 10:50h

Comunicado de imprensa: AAOS Updates Clinical Practice Guideline for Osteoarthritis of the Knee – American Academy of Orthopaedic Surgeons

Resumo da diretriz: Management of Osteoarthritis of the Knee (Non-Arthroplasty) (3rd Edition) – American Academy of Orthopaedic Surgeons

Artigo completo: Management of Osteoarthritis of the Knee (Non-Arthroplasty) Evidence-Based Clinical Practice Guideline

Um painel da FDA afirma que somente americanos de alto risco e os maiores de 65 anos deveriam tomar as doses de reforço contra Covid.

20 Set, 2021 | 13:56h

An FDA Panel Says Only High-Risk Americans And Those 65+ Should Get COVID Boosters – NPR

Ver também:

FDA advisory panel recommends booster doses of Covid-19 vaccine only for older and high-risk Americans – STAT

5 reasons why FDA advisers did not recommend Covid-19 booster shots for everyone – CNN

Top doctors say not so fast to Biden’s boosters-for-all plan – Associated Press

Conteúdos relacionados:

An observational study in Israel suggests additional protection from a 3rd dose of the Pfizer vaccine in individuals 60 years of age or older.

Third shot: UK to offer COVID booster jabs to over 50s.

COVID-19 vaccine efficacy does not support boosters for general population, review concludes.

COVID vaccine effects wane over time but still prevent death and severe illness.

What’s the evidence for COVID-19 booster shots?

WHO appeals for countries to postpone COVID-19 vaccine boosters until 2022 to prioritize vaccinating the most at-risk people around the world who are yet to receive their first dose.

AstraZeneca bosses warn against rush for boosters – “giving the most vulnerable, who may not have built up a full immune response from the first two, a third, top-up dose is “sensible”. But any decision to give a third, booster jab “to large swathes of the population”, to extend their protection from the first two, must be based on clinical data”.

Diretriz AAN | Considerações éticas sobre o diagnóstico e o cuidado da demência.

17 Set, 2021 | 12:59h

Ethical Considerations in Dementia Diagnosis and Care: AAN Position Statement – Neurology

Estudo observacional em Israel sugere proteção adicional da terceira dose da vacina da Pfizer em pessoas com mais de 60 anos de idade.

17 Set, 2021 | 12:42h

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel – New England Journal of Medicine

Ponto de vista | Tratamento de multimorbidade em pacientes idosos: já estamos prontos para a medicina de precisão na terapia intensiva?

14 Set, 2021 | 14:14h

The management of multi-morbidity in elderly patients: Ready yet for precision medicine in intensive care? – Critical Care

Estudo mostra que a decisão de “não ressuscitar” é registrada somente em 1 a cada 5 pacientes idosos, muito doentes e hospitalizados.

14 Set, 2021 | 14:08h

‘Do not resuscitate’ decision recorded for only 1 in 5 very sick older patients, study finds – News Medical

Estudo original: Do not attempt cardiopulmonary resuscitation (DNACPR) decisions for older medical inpatients: a cohort study – BMJ Supportive & Palliative Care

Risco de Covid-19 severa em indivíduos já vacinados é maior para idosos e pessoas com condições subjacentes.

12 Set, 2021 | 22:22h

Risk of severe breakthrough Covid-19 higher for seniors and people with underlying conditions – CNN

Estudo original: Hospitalisation among vaccine breakthrough COVID-19 infections – The Lancet Infectious Diseases

Comunicado de imprensa: Study examines severe breakthrough cases of COVID-19 – YaleNews

 

Comentário no Twitter

 

Pessoas com doença de Parkinson podem se beneficiar de 7 estratégias de caminhada.

12 Set, 2021 | 22:04h

Comunicado de imprensa: People with Parkinson’s may benefit from seven walking strategies – American Academy of Neurology

Estudo original: Perception and Use of Compensation Strategies for Gait Impairment by Persons With Parkinson Disease – Neurology

Comentário: Compensation Strategies Benefit Parkinson Patients With Gait Impairment – HealthDay

 

Comentário no Twitter (fio – clique para saber mais)

 

Editorial | Drogas anticolinérgicas e demência: hora de transparência diante da incerteza.

12 Set, 2021 | 20:11h

Anticholinergic drugs and dementia: time for transparency in the face of uncertainty – Cochrane Library

Revisão sistemática: Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome – Cochrane Library

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.